<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref67">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>Y. T.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K. H.</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>E. J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M. C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y. N.</given-names>
   </name>
   <name>
    <surname>Hwang</surname>
    <given-names>H. S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles</article-title>. 
  <source>Virology</source>
  <volume>529</volume>, 
  <fpage>111</fpage>â€“
  <lpage>121</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.virol.2019.01.017</pub-id>, PMID: 
  <?supplied-pmid 30685658?>
  <pub-id pub-id-type="pmid">30685658</pub-id>
 </mixed-citation>
</ref>
